Thus, administration of IL-10 has been recommended to treat ARDS in COVID-19.184 However, a recent report showed that IL-10 may be detrimental in the initiation phase of SARS-CoV-2 infection by promoting T cell exhaustion. This evidence concerns the gene IL10 and COVID-19.